Experiment 324917

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPHARMACEUTICAL FORMULATION OFEFFECTS DUE TO A COMBINATION OF DRUGSCOMPLEX FORMATIONSTABILITY STUDIES OFANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

ERYTHROMYCIN

Details

PropertyValue
Pharmacology
ANTIMICROBIAL ACTIVITY(UNSPECIFIED)
Administration routeINTRAMAMMARY
OrganismEmpty organism
CitationALYUSHIN,MT: VETRA,J: VAIDERS,L: SKOPETS,AG:. (1973). PRODUCTION AND TESTING OF A PHARMACEUTICAL FORMULATION FOR TREATING MASTITIS IN COWS. II. EFFECT OF AN ERYTHROMYCIN-SULFADIMAZINE OINTMENT MADE WITH ESILON-5 BASE ON THE CLINICAL INDEXES OF LABORATORY ANIMALS AND COWS.. 1973()
Amount utilized
Compound isolated
DiseaseMASTITIS
Number1
Qualitative resultACTIVE
AnimalCOW